Showing 13,301 - 13,320 results of 121,244 for search '(( 2 e decrease ) OR ( 5 ((((ng decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.90s Refine Results
  1. 13301

    Sodium-Glucose Transporter-2 (SGLT2; SLC5A2) Enhances Cellular Uptake of Aminoglycosides by Meiyan Jiang (438439)

    Published 2014
    “…Yet, the ototoxic and nephrotoxic side-effects of these drugs remain serious complications. A major site of gentamicin uptake and toxicity resides within kidney proximal tubules that also heavily express electrogenic sodium-glucose transporter-2 (SGLT2; SLC5A2) <i>in vivo</i>. …”
  2. 13302
  3. 13303
  4. 13304

    Survival of immunocompetent AJ mice with Neuro-2a murine neuroblastoma tumors treated with R3659 or M002. by Lauren A. Gillory (469462)

    Published 2013
    “…<p>Neuro-2a murine neuroblastoma tumor cells (5 × 10<sup>5</sup> cells) were injected into the right flank of immunocompetent syngeneic AJ mice. …”
  5. 13305
  6. 13306
  7. 13307
  8. 13308

    Examining the Out-of-Center Distortion in the [NbOF<sub>5</sub>]<sup>2-</sup> Anion by Heather K. Izumi (2652805)

    Published 2005
    “…Out-of-center “primary” electronic distortions are inherent to the oxide fluoride anions of the early d<sup>0</sup> transition metals. In the [NbOF<sub>5</sub>]<sup>2-</sup> anion, the Nb<sup>5+</sup> moves from the center of the octahedron toward the oxide ligand to form a short NbO bond and long trans Nb−F bond. …”
  9. 13309
  10. 13310
  11. 13311
  12. 13312
  13. 13313
  14. 13314

    Increased hydrophilic plasma bile acids are correlated with protection from adiposity in skin-specific stearoyl-CoA desaturase-1 deficient mice by Sabrina N. Dumas (5474456)

    Published 2018
    “…Bile acid signaling through the bile acid-specific receptor TGR5 is known to be protective against obesity and metabolic disease; a phenotype that is similar to SKO mice. …”
  15. 13315
  16. 13316
  17. 13317
  18. 13318
  19. 13319

    Data Sheet 5_Unravelling the impact of SARS-CoV-2 on hemostatic and complement systems: a systems immunology perspective.xlsx by Didar Murad (12220805)

    Published 2025
    “…Simulation results highlight key components affected, including thrombin, tissue plasminogen activator, plasmin, fibrin degradation products, interleukin 6 (IL-6), the IL-6 and IL-6R complex, and the terminal complement complex (C5b-9). We explored that the decreased levels of complement factor H and C1-inhibitor significantly elevate these components, whereas tissue factor pathway inhibitor and alpha-2-macroglobulin have more modest effects. …”
  20. 13320